Literature DB >> 1846266

Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice. Characterization of infiltrating cells.

P Price1, K S Eddy, J M Papadimitriou, D L Faulkner, G R Shellam.   

Abstract

Carditis developed 7 days after the administration of murine cytomegalovirus to neonatal, young adult or aged mice of varying sensitivity to lethal infection with this virus. The inflammation persisted for up to 80 days, but infected myocardial cells were rare and were not seen after day 10. The inflammatory cells comprised macrophages (up to 30%) and T cells (up to 80%), with a high ratio of Lyt2+ to L3T4+ cells throughout. Although the H-2 genotype affects murine cytomegalovirus replication at the level of individual cells, and hence resistance to lethal infection, it did not determine resistance to cardiopathy per se. However BALB/c, BALB.B, and BALB.K mice developed persistent myocarditis regardless of age at infection, and age-related cardiopathy was frequent and severe in infected and uninfected mice. B10 and B10.BR mice also developed myocarditis after neonatal infection, but inflammation resolved rapidly after adult infection and age-related cardiopathy was correspondingly mild. C3H mice exhibited minimal carditis after neonatal or adult infection. However neonatal infection appears to accelerate age-related cardiopathy, which is severe in retired breeders of this strain.

Entities:  

Mesh:

Year:  1991        PMID: 1846266      PMCID: PMC1886054     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Deposition induced by hydrocortisone of calcium in the heart tissue of female C3H mice.

Authors:  A LOSTROH; C H LI
Journal:  Nature       Date:  1955-09-10       Impact factor: 49.962

2.  Hydrops fetalis with supraventricular tachycardia and cytomegalovirus infection.

Authors:  F Filloux; D K Kelsey; C L Bose; L G Veasy; W M Gooch
Journal:  Clin Pediatr (Phila)       Date:  1985-09       Impact factor: 1.168

Review 3.  Epidemiology and transmission of cytomegalovirus.

Authors:  R F Pass
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

4.  Replication of cytomegalovirus in human arterial smooth muscle cells.

Authors:  J J Tumilowicz; M E Gawlik; B B Powell; J J Trentin
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  Activation of latent murine cytomegalovirus in cardiac explant and cell cultures.

Authors:  E J Wilson; D N Medearis; L V Barrett; R H Rubin
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

6.  T-lymphocyte subpopulations and function during murine cytomegalovirus infection.

Authors:  M S Sell; J F Bale; R H Giller
Journal:  Pediatr Res       Date:  1985-06       Impact factor: 3.756

7.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.

Authors:  L J Wolfgram; K W Beisel; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice.

Authors:  G R Shellam; J P Flexman
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

9.  Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection.

Authors:  D L Gang; L V Barrett; E J Wilson; R H Rubin; D N Medearis
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

10.  Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood.

Authors:  C Kishimoto; T Misaki; C S Crumpacker; W H Abelmann
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

View more
  9 in total

1.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  TLRs and NODs mRNA expression pattern in healthy mouse eye.

Authors:  S Rodríguez-Martínez; M E Cancino-Díaz; L Jiménez-Zamudio; E García-Latorre; J C Cancino-Díaz
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  C.B-17 SCID mice develop epicardial calcinosis with unaltered cardiac function.

Authors:  Suchi Raghunathan; Corey L Reynolds; Robert J Schwartz; M David Stewart; Bradley K McConnell
Journal:  Fundam Clin Pharmacol       Date:  2018-08-05       Impact factor: 2.748

4.  Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.

Authors:  S D Reed; S Li
Journal:  Cancer Gene Ther       Date:  2011-01-14       Impact factor: 5.987

5.  Cardiac autoimmunity in HIV related heart muscle disease.

Authors:  P F Currie; J H Goldman; A L Caforio; A J Jacob; M K Baig; R P Brettle; A J Haven; N A Boon; W J McKenna
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice.

Authors:  B T Ivandic; J H Qiao; D Machleder; F Liao; T A Drake; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice.

Authors:  S D Olver; P Price; G R Shellam
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Authors:  A J Chapman; H E Farrell; J A Thomas; J M Papadimitriou; M J Garlepp; A A Scalzo; G R Shellam
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

9.  B-cell activation following murine cytomegalovirus infection: implications for autoimmunity.

Authors:  P Price; S D Olver; A E Gibbons; G R Shellam
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.